Comparison of Vital Status, Cause of Death, and Follow-Up after Hematopoietic Cell Transplantation in Linked Center for International Blood and Marrow Transplant Research and California Cancer Registry Data, 1991 to 2018
Bryan Valcárcel(Milken Institute), Lindsay M. Morton(National Cancer Institute), Lori Muffly(Stanford University), Renata Abrahão(University of California Davis Medical Center), Sara J. Schonfeld(National Cancer Institute), Bronwen E. Shaw(Royal Marsden NHS Foundation Trust), Eric A. Engels(National Cancer Institute), Paul S. Albert(National Cancer Institute), Ann Brunson(UC Davis Comprehensive Cancer Center), Christa L. Meyer(National Marrow Donor Program), Stephen R. Spellman(National Marrow Donor Program), Shahinaz M. Gadalla(Division of Cancer Epidemiology and Genetics), Julianne J.P. Cooley(UC Davis Comprehensive Cancer Center), J. Douglas Rizzo, Jeffery J. Auletta(Nationwide Children's Hospital), Theresa H.M. Keegan(UC Davis Comprehensive Cancer Center), Ted Wun(UC Davis Comprehensive Cancer Center)
Cited by 3
Related Papers
2016 US lymphoid malignancy statistics by World Health Organization subtypes
|CA A Cancer Journal for Clinicians|2016|1.1k
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
|JNCI Journal of the National Cancer Institute|2005|830
Cancer Burden in the HIV-Infected Population in the United States
|JNCI Journal of the National Cancer Institute|2011|775
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
|Transplantation and Cellular Therapy|2020|718